390 results on '"K. Thoma"'
Search Results
202. [On the investigation of antiseptic ointments by means of agar diffusion tests. 2. Communication on the significance of surface-active substances in the manufacture of medicinal preparations]
- Author
-
E, ULLMANN and K, THOMA
- Subjects
Ointments ,Agar ,Anti-Infective Agents, Local ,Humans - Published
- 1959
203. [The influence of ammonium bituminosulfonate on cationic active drugs. 3. On the significance of surface-active substances in the manufacture of drug preparations]
- Author
-
E, ULLMANN, K, THOMA, and B, MOSER
- Subjects
Quaternary Ammonium Compounds ,Surface-Active Agents ,Cations ,Drug Compounding ,Ammonium Compounds ,Anti-Infective Agents, Local ,Humans ,Sulfonic Acids - Published
- 1961
204. [On the question of an influence of 'hydrophilic-lipophilic balance (HLB-value)' of tensio-active compounds on the yield and effect of antibacterial substances. 16. On the influence of adjuvant substances in the preparation of drugs]
- Author
-
K, Thoma
- Subjects
Surface-Active Agents ,Anti-Infective Agents ,Drug Compounding - Published
- 1967
205. [Binding of mechanism of nicotinic acid esters to homologous polyethylene glycol fat alcohol ethers. 21. Effects of adjuvants in the preparation of drugs]
- Author
-
E, Ullmann, K, Thoma, and B C, Lippold
- Subjects
Glycols ,Surface-Active Agents ,Binding Sites ,Drug Compounding ,Nicotinic Acids ,Esters ,Pharmaceutical Vehicles ,Polyethylenes ,Ethers - Published
- 1972
206. Environmental menstrual disorders
- Author
-
S, Matsumoto, K, Thoma, H, Kubo, M, Watanabe, H, Hosaka, and A, Utsuno
- Subjects
Adult ,Adolescent ,Japan ,Humans ,Female ,Environment ,Menstruation Disturbances - Published
- 1965
207. [ON THE QUANTITATIVE DETERMINATION OF SURFACE ACTIVE QUARTERNARY AMMONIUM COMPOUNDS (INVERT SOAP) BY A FLOCCULATION REACTION. 2. ON THE DETERMINATION OF SURFACE ACTIVE SUBSTANCES]
- Author
-
K, THOMA, E, ULLMANN, and P, LOOS
- Subjects
Quaternary Ammonium Compounds ,Surface-Active Agents ,Research ,Ammonium Compounds ,Anti-Infective Agents, Local ,Flocculation ,Soaps ,Chemistry Techniques, Analytical - Published
- 1963
208. [On the analysis of sodium suramine. 10. Report on the determination of pharmaceutic aids and drugs]
- Author
-
K, Thoma, E, Ullmann, and P, Loos
- Subjects
Sodium ,Lactates ,Methods ,Pharmaceutic Aids ,Acridines ,Suramin - Published
- 1967
209. [A CONTRIBUTION TO THE AVOIDANCE OF NON-SPECIFIC REACTIONS IN INDIRECT BLOOD GROUP TESTS]
- Author
-
K, THOMA
- Subjects
Hematologic Tests ,Blood Group Antigens ,Humans - Published
- 1963
210. [Extent and causes of binding of phenols by polethylene glycol stearates. Reciprocal inhibiting action of disinfectants and preservatives with non-ionogenic tensides. II]
- Author
-
K, Thoma, E, Ullmann, and O, Fickel
- Subjects
Glycols ,Phenols ,Chemistry, Pharmaceutical ,Depression, Chemical ,Staphylococcus ,Pharmaceutic Aids ,Polyethylenes ,Disinfectants - Published
- 1970
211. Der mikrochemische Arsennachweis und seine Brauchbarkeit zur Identifizierung von Menstruationsblut
- Author
-
E. Kuchinke, K. Thoma, and A. Schöntag
- Subjects
Pharmacology ,Gynecology ,medicine.medical_specialty ,business.industry ,Pharmacology toxicology ,medicine ,General Medicine ,business - Abstract
Es wird eine mikrochemische Testfleckenmethode zur Bestimmung von Arsen beschrieben. Das Verfahren gestattet noch 0,05 γ As zu erfassen. Fehlermoglichkeiten sind durch die kombinierte Auswertung der Testflecken (Messung des Reflexionsvermogens, quantitative spektrographische Analyse) praktisch ausgeschlossen.
- Published
- 1955
- Full Text
- View/download PDF
212. [Microbiological studies on the diffusion of antiseptics from ointment bases. 15. Report on the effect of pharmaceutic aids in the preparation of drug preparations]
- Author
-
K, Thoma, E, Ullmann, and H, Macionga
- Subjects
Ointments ,Chemical Phenomena ,Chemistry, Physical ,Sulfates ,Drug Compounding ,Staphylococcus ,Anti-Infective Agents, Local ,Quinolines ,Acridines ,Emulsions - Published
- 1967
213. [SALIVA TEST WITH TRIPHENYLTETRAZOLIUM CHLORIDE INCLUDING INDIRECT BLOOD GROUP DETERMINATION FROM TRACES OF SALIVA]
- Author
-
K, THOMA
- Subjects
Blood Grouping and Crossmatching ,Blood Group Antigens ,Humans ,Tetrazolium Salts ,Ascorbic Acid ,Forensic Medicine ,Saliva ,Chemistry Techniques, Analytical - Published
- 1964
214. [On the determination of the content of acridine derivates. 7. On the determination of pharmaceutical adjuvants and medicaments]
- Author
-
K, Thoma, E, Ullmann, and P, Loos
- Subjects
Surface-Active Agents ,Pharmaceutical Preparations ,Quinacrine ,Sulfates ,Agglutination Tests ,Chemistry, Pharmaceutical ,Acridines - Published
- 1966
215. [Use of ribonuclease (Brachet's test) in hematologic diagnosis]
- Author
-
K, THOMA
- Subjects
Leukemia ,Ribonucleases ,Staining and Labeling ,Humans ,Coloring Agents - Published
- 1950
216. [Structure-dependent correlations of silicon compounds with drugs. 13. A report on the effect of auxiliary substances in the production of drug preparations]
- Author
-
K, Thoma, E, Ullmann, and E, Wolferseder
- Subjects
Quaternary Ammonium Compounds ,Pyridines ,Adsorption ,Powders ,Silicon Dioxide - Published
- 1966
217. [Decrease in the value of drugs by inorganic gel formers. 5. On the effect of adjuvants in the manufacture of drug preparations]
- Author
-
K, THOMA, E, ULLMANN, and E, WOLFERSEDER
- Subjects
Drug Compounding ,Humans ,Gels ,Adjuvants, Pharmaceutic - Published
- 1962
218. [Binding capacity of polyvinylpyrrolidone for local anesthetics. 20. Effect of pharmaceutic aids in the preparation of drugs]
- Author
-
E, Ullmann, K, Thoma, and P, Mohrschulz
- Subjects
Pharmaceutic Aids ,Povidone ,Technology, Pharmaceutical ,Anesthetics, Local - Published
- 1969
219. [DEMONSTRATION AND IDENTIFICATION OF SURFACE-ACTIVE ESTERS AND ETHERS OF POLYETHYLENE GLYCOLS WITH THIN-LAYER CHROMATOGRAPHY. 6. ON THE DETERMINATION OF PHARMACEUTICAL AIDS]
- Author
-
K, THOMA, R, ROMBACH, and E, ULLMANN
- Subjects
Chromatography ,Glycols ,Surface-Active Agents ,Research ,Pharmaceutic Aids ,Esters ,Chromatography, Thin Layer ,Polyethylenes ,Ethers ,Polyethylene Glycols - Published
- 1965
220. The mining-induced displacement and resettlement: The church as a leaven and ecclesiology in context’s response
- Author
-
K. Thomas Resane
- Subjects
The Bible ,BS1-2970 ,Practical Theology ,BV1-5099 - Abstract
Natural resources, especially minerals from the earth, are to be protected by humanity. The church, which acts as leaven in the world is called to rise and address the unfriendly mining activities called mining-induced displacement and resettlement (MIDR). The general theory of interpretation of creation account calls for human stewardship in the world. Humans must view themselves as partners with God in preserving and sustaining the cosmos. The communities had suffered negative socio-economic imbalances. The ekklesia in this cosmic chaos is called upon to fulfil four major functions, namely identity, integration, policy, and management as a way of intervention in communities that are victims of these mining activities. This response, ecclesiology in context, is the combination of theological and social-scientific approaches to the development of practical models and strategies for the church’s interaction with modern society and its challenges.
- Published
- 2015
- Full Text
- View/download PDF
221. Proceedings of the Frontiers of Retrovirology Conference 2016
- Author
-
Irena Zurnic, Sylvia Hütter, Ute Lehmann, Nicole Stanke, Juliane Reh, Tobias Kern, Fabian Lindel, Gesche Gerresheim, Martin Hamann, Erik Müllers, Paul Lesbats, Peter Cherepanov, Erik Serrao, Alan Engelman, Dirk Lindemann, Claire Da Silva Santos, Kevin Tartour, Andrea Cimarelli, Rya Burdick, Jianbo Chen, Jaya Sastri, Wei-Shau Hu, Vinay Pathak, Oliver T. Keppler, Karine Pradeau, Sylvia Eiler, Nicolas Levy, Sarah Lennon, Sarah Cianferani, Stéphane Emiliani, Marc Ruff, Vincent Parissi, Sylvie Rato, Antonio Rausell, Miguel Munoz, Amalio Telenti, Angela Ciuffi, Alexander Zhyvoloup, Anat Melamed, Ian Anderson, Delphine Planas, Janos Kriston-Vizi, Robin Ketteler, Chen- Hsuin Lee, Andy Merritt, Petronela Ancuta, Charles Bangham, Ariberto Fassati, Anthony Rodari, Benoit Van Driessche, Mathilde Galais, Nadége Delacourt, Sylvain Fauquenoy, Caroline Vanhulle, Anna Kula, Arsène Burny, Olivier Rohr, Carine Van Lint, Thijs van Montfort, Renee van der Sluis, Dave Speijer, Ben Berkhout, Bo Meng, Andrzej Rutkowski, Neil Berry, Lars Dölken, Andrew Lever, Thomas Schuster, Benedikt Asbach, Ralf Wagner, Christine Gross, Veit Wiesmann, Martina Kalmer, Thomas Wittenberg, Jan Gettemans, Andrea K. Thoma-Kress, Minghua Li, Eric O. Freed, Shan-Lu Liu, Janis Müller, Jan Münch, Xaver Sewald, Pradeep Uchil, Mark Ladinsky, Jagadish Beloor, Ruoxi Pi, Christin Herrmann, Nasim Motamedi, Thomas Murooka, Michael Brehm, Dale Greiner, Thorsten Mempel, Pamela Bjorkman, Priti Kumar, Walther Mothes, Simone Joas, Erica Parrish, Clement Wesley Gnanadurai, Edina Lump, Christina M. Stürzel, Nicholas F. Parrish, Ulrike Sauermann, Katharina Töpfer, Tina Schultheiss, Steven Bosinger, Guido Silvestri, Cristian Apetrei, Nicholas Huot, Michaela Müller-Trutwin, Daniel Sauter, Beatrice H. Hahn, Christiane Stahl-Hennig, Frank Kirchhoff, Gerald Schumann, Sabine Jung-Klawitter, Nina V. Fuchs, Kyle R. Upton, Martin Muñoz-Lopez, Ruchi Shukla, Jichang Wang, Marta Garcia-Canadas, Cesar Lopez-Ruiz, Daniel J. Gerhardt, Attila Sebe, Ivana Grabundzija, Patricia Gerdes, Sylvia Merkert, Andres Pulgarin, Anja Bock, Ulrike Held, Anett Witthuhn, Alexandra Haase, Ernst J. Wolvetang, Ulrich Martin, Zoltán Ivics, Zsuzsanna Izsvák, J. Garcia-Perez, Geoffrey J. Faulkner, Tara Hurst, Aris Katzourakis, Gkikas Magiorkinis, Kerstin Schott, Rita Derua, Janna Seifried, Andreas Reuter, Heike Schmitz, Christiane Tondera, Alberto Brandariz-Nuñez, Felipe Diaz-Griffero, Veerle Janssens, Renate König, Hanna-Mari Baldauf, Lena Stegmann, Sarah-Marie Schwarz, Maud Trotard, Margarethe Martin, Gina Lenzi, Manja Burggraf, Xiaoyu Pan, Oliver I. Fregoso, Efrem S. Lim, Libin Abraham, Elina Erikson, Laura Nguyen, Ina Ambiel, Frank Rutsch, Baek Kim, Michael Emerman, Oliver T. Fackler, Sabine Wittmann, Rayk Behrendt, Bianca Volkmann, Kristin Eissmann, Thomas Gramberg, Sebastian Bolduan, Herwig Koppensteiner, Stefanie Regensburg, Ruth Brack-Werner, Rika Draenert, Michael Schindler, Aurélie Ducroux, Shuting Xu, Aparna Ponnurangam, Sergej Franz, Angelina Malassa, Ellen Ewald, Christine Goffinet, Sin-Yee Fung, Ching-Ping Chan, Chun-Kit Yuen, Kin-Hang Kok, Chin-Ping Chan, Dong-Yan Jin, Ulf Dittmer, Dorota Kmiec, Shilpa Iyer, Christina Stürzel, Beatrice Hahn, Yasuo Ariumi, Mariko Yasuda-Inoue, Koudai Kawano, Satoshi Tateishi, Priscilla Turelli, Alex Compton, Nicolas Roy, Françoise Porrot, Anne Billet, Nicoletta Casartelli, Jacob Yount, Chen Liang, Oliver Schwartz, Carsten Magnus, Lucia Reh, Penny Moore, Therese Uhr, Jacqueline Weber, Lynn Morris, Alexandra Trkola, Rashel V. Grindberg, Erika Schlaepfer, Gideon Schreiber, Viviana Simon, Roberto F. Speck, Zeger Debyser, Lenard Vranckx, Jonas Demeulemeester, Suha Saleh, Eric Verdin, Anna Cereseto, Frauke Christ, Rik Gijsbers, Gang Wang, Na Zhao, Atze T. Das, Josef Köstler, Beatriz Perdiguero, Mariano Esteban, Bertram L. Jacobs, David C. Montefiori, Celia C. LaBranche, Nicole L. Yates, Georgia D. Tomaras, Guido Ferrari, Kathryn E. Foulds, Mario Roederer, Gary Landucci, Donald N. Forthal, Michael S. Seaman, Natalie Hawkins, Steven G. Self, Sanjay Phogat, James Tartaglia, Susan W. Barnett, Brian Burke, Anthony D. Cristillo, Song Ding, Jonathan L. Heeney, Giuseppe Pantaleo, Viktoria Stab, Armin Ensser, Bettina Tippler, Dennis Burton, Matthias Tenbusch, Klaus Überla, Galit Alter, Giuseppe Lofano, Anne-Sophie Dugast, Viraj Kulkarni, Todd Suscovich, Tatiana Opazo, Felipe Barraza, Diego Herrera, Andrea Garces, Tomas Schwenke, Diego Tapia, Jorge Cancino, Gloria Arriagada, Christina Haußner, Dominik Damm, Anette Rohrhofer, Barbara Schmidt, Jutta Eichler, Rebecca Midgley, James Wheeldon, Vincent Piguet, Priyanka Khopkar, Megha Rohamare, Smita Kulkarni, Ana Godinho-Santos, Allan Hance, Joao Goncalves, Fabrizio Mammano, Romain Gasser, Meriem Hamoudi, Martina Pellicciotta, Zhicheng Zhou, Clara Visdeloup, Philippe Colin, Martine Braibant, Bernard Lagane, Matteo Negroni, Jula Wamara, Norbert Bannert, Thibault Mesplede, Nathan Osman, Kaitlin Anstett, Jiaming Calvin Liang, Hanh Thi Pham, Mark Wainberg, Wei Shao, Jigui Shan, Mary Kearney, Xiaolin Wu, Frank Maldarelli, John Mellors, Brian Luke, John Coffin, Stephen Hughes, Thomas Fricke, Silvana Opp, Caitlin Shepard, Dmitri Ivanov, Jose Valle-Casuso, Marine Kanja, Pierre Cappy, Daniela Lener, Ekaterina Knyazhanskaya, Andrey Anisenko, Timofey Zatsepin, Marina Gottikh, Alexander Komkov, Anastasia Minervina, Gaiaz Nugmanov, Vadim Nazarov, Konstantin Khodosevich, Ilgar Mamedov, Yuri Lebedev, Marta Colomer-Lluch, Ruth Serra-Moreno, Ambra Sarracino, Lavina Gharu, Alexander Pasternak, Alessandro Marcello, Ann Marie McCartin, Anurag Kulkarni, Valentin Le Douce, Virginie Gautier, Ann Baeyens, Evelien Naessens, Anouk Van Nuffel, Karin Weening, Anne- Marie Reilly, Eva Claeys, Wim Trypsteen, Linos Vandekerckhove, Sven Eyckerman, Kris Gevaert, Bruno Verhasselt, Hoi Ping Mok, Nicholas Norton, Axel Fun, Jack Hirst, Mark Wills, Dalibor Miklik, Filip Senigl, Jiri Hejnar, Jun-ichi Sakuragi, Sayuri Sakuragi, Masaru Yokoyama, Tatsuo Shioda, Hironori Sato, Jochen Bodem, Rebecca Moschall, Sarah Denk, Steffen Erkelenz, Christian Schenk, Heiner Schaal, Norbert Donhauser, Ellen Socher, Sebastian Millen, Heinrich Sticht, Melanie Mann, Guochao Wei, Matthew J. Betts, Yang Liu, Timo Kehl, Robert B. Russell, Martin Löchelt, Oliver Hohn, Saeed Mostafa, Kirsten Hanke, Stephen Norley, Chia-Yen Chen, Masashi Shingai, Pedro Borrego, Nuno Taveira, Klaus Strebel, Chris Hellmund, Melanie Friedrich, Friedrich Hahn, Christian Setz, Pia Rauch, Kirsten Fraedrich, Alina Matthaei, Petra Henklein, Maximilian Traxdorf, Torgils Fossen, Ulrich Schubert, Aya Khwaja, Meytal Galilee, Akram Alian, Birco Schwalbe, Heiko Hauser, Michael Schreiber, Mirte Scherpenisse, Young-Keol Cho, Jungeun Kim, Daeun Jeong, Katerina Trejbalova, Martina Benesova, Dana Kucerova, Zdenka Vernerova, Rachel Amouroux, Petra Hajkova, Daniel Elleder, Tomas Hron, Helena Farkasova, Abinash Padhi, Jan Paces, Henan Zhu, Robert Gifford, Pablo Murcia, Maria Luisa Carrozza, Anna-Maria Niewiadomska, Maurizio Mazzei, Mounir Abi-Said, Joseph Hughes, Stéphane Hué, Adetayo Obasa, Graeme Jacobs, Susan Engelbrecht, Katharina Mack, Kathrin Starz, Matthias Geyer, Frederic Bibollet-Ruche, Marie Leoz, Jean Christophe Plantier, Ayele Argaw-Denboba, Emanuela Balestrieri, Annalucia Serafino, Ilaria Bucci, Chiara Cipriani, Corrado Spadafora, Paolo Sinibaldi-Vallebona, Claudia Matteucci, S. Nandi Jayashree, Ujjwal Neogi, Anil K. Chhangani, Shravan Sing Rathore, Bajrang R. J. Mathur, Adeyemi Abati, B. Taylan Koç, Tuba Çiğdem Oğuzoğlu, Takatoshi Shimauchi, Stephan Caucheteux, Jocelyn Turpin, Katja Finsterbusch, Yoshiki Tokura, Shanti Souriant, Luciana Balboa, Karine Pingris, Denise Kviatcowsky, Brigitte Raynaud-Messina, Céline Cougoule, Ingrid Mercier, Marcelo Kuroda, Pablo González-Montaner, Sandra Inwentarz, Eduardo Jose Moraña, Maria del Carmen Sasiain, Olivier Neyrolles, Isabelle Maridonneau-Parini, Geanncarlo Lugo-Villarino, Christel Vérollet, Alexandra Herrmann, Dominique Thomas, Nerea Ferreirós Bouzas, Xavier Lahaye, Anvita Bhargava, Takeshi Satoh, Matteo Gentili, Silvia Cerboni, Aymeric Silvin, Cécile Conrad, Hakim Ahmed-Belkacem, Elisa C. Rodriguez, Jean-François Guichou, Nathalie Bosquet, Matthieu Piel, Roger Le Grand, Megan King, Jean-Michel Pawlotsky, Nicolas Manel, Henning Hofmann, Benedicte Vanwalscappel, Nicolin Bloch, Nathaniel Landau, Stanislav Indik, Benedikt Hagen, José Carlos Valle-Casuso, Awatef Allouch, Annie David, Françoise Barré-Sinoussi, Monsef Benkirane, Gianfranco Pancino, Asier Saez-Cirion, Wing-Yiu Lee, Richard Sloan, Bianca Schulte, Jonas Blomberg, Luana Vargiu, Patricia Rodriguez-Tomé, Enzo Tramontano, Göran Sperber, Namita Kumari, Tatiana Ammosova, Sharmeen Diaz, Patricia Oneal, Sergei Nekhai, Audrey Fahrny, Gustavo Gers-Huber, Annette Audigé, Anitha Jayaprakash, Ravi Sachidanandam, Matt Hernandez, Marsha Dillon-White, Emmanuel Maze, Claire Ham, Neil Almond, Greg Towers, Robert Belshaw, Patrícia de Sousa-Pereira, Joana Abrantes, Massimo Pizzato, Pedro J. Esteves, Tanja Kahle, Sven Schmitt, Laura Merkel, Nina Reuter, Thomas Stamminger, Ilaria Dalla Rosa, Kate Bishop, Antonella Spinazzola, Harriet Groom, Gabrielle Vieyres, Mathias Müsken, Thomas Zillinger, Veit Hornung, Winfried Barchet, Susanne Häussler, Thomas Pietschmann, Aneela Javed, Nicole Leuchte, Gabriela Salinas, Lennart Opitz, Sieghart Sopper, Christiane Mummert, Christian Hofmann, Angela G. Hückelhoven, Silke Bergmann, Sandra M. Müller-Schmucker, Ellen G. Harrer, Jan Dörrie, Niels Schaft, Thomas Harrer, Laure Cardinaux, M.- L. Zahno, H.- R. Vogt, R. Zanoni, G. Bertoni, Maximilian Muenchhoff, Philip Goulder, Oliver Keppler, Stephanie Rebensburg, Markus Helfer, Yuwei Zhang, Huicheng Chen, Annie Bernier, Annie Gosselin, Jean- Pierre Routy, Birgitta Wöhrl, Anna Schneider, Angela Corona, Imke Spöring, Mareike Jordan, Bernd Buchholz, Elias Maccioni, Roberto Di Santo, Kristian Schweimer, Christian Schölz, Brian Weinert, Sebastian Wagner, Petra Beli, Yasuyuki Miyake, Jun Qi, Lars Jensen, Werner Streicher, Anna McCarthy, Nicholas Westwood, Sonia Lain, Jürgen Cox, Patrick Matthias, Matthias Mann, James Bradner, Chunaram Choudhary, Marcel Stern, Elena Valletta, Caterina Frezza, Francesca Marino-Merlo, Sandro Grelli, Anna Lucia Serafino, Antonio Mastino, Beatrice Macchi, Meike Kaulfuß, Sonja Windmann, Wibke Bayer, Sello Mikasi, Rebecca Heß, Michael Storcksdieck gen. Bonsmann, Carsten Kirschning, Bernd Lepenies, Anne Kolenbrander, Vladimir Temchura, Kenta Iijima, Junya Kobayashi, and Yukihito Ishizaka
- Subjects
0301 basic medicine ,03 medical and health sciences ,030104 developmental biology ,Infectious Diseases ,Retroviral infection ,Virology ,Pandemic ,Biology ,Meeting Abstracts - Abstract
Table of contents Oral presentations Session 1: Entry & uncoating O1 Host cell polo-like kinases (PLKs) promote early prototype foamy virus (PFV) replication Irena Zurnic, Sylvia Hütter, Ute Lehmann, Nicole Stanke, Juliane Reh, Tobias Kern, Fabian Lindel, Gesche Gerresheim, Martin Hamann, Erik Müllers, Paul Lesbats, Peter Cherepanov, Erik Serrao, Alan Engelman, Dirk Lindemann O2 A novel entry/uncoating assay reveals the presence of at least two species of viral capsids during synchronized HIV-1 infection Claire Da Silva Santos, Kevin Tartour, Andrea Cimarelli O3 Dynamics of nuclear envelope association and nuclear import of HIV-1 complexes Rya Burdick, Jianbo Chen, Jaya Sastri, Wei-Shau Hu, Vinay Pathak O4 Human papillomavirus protein E4 potently enhances the susceptibility to HIV infection Oliver T. Keppler Session 2: Reverse transcription & integration O5 Structure and function of HIV-1 integrase post translational modifications Karine Pradeau, Sylvia Eiler, Nicolas Levy, Sarah Lennon, Sarah Cianferani, Stéphane Emiliani, Marc Ruff O6 Regulation of retroviral integration by RNA polymerase II associated factors and chromatin structure Vincent Parissi Session 3: Transcription and latency O7 A novel single-cell analysis pipeline to identify specific biomarkers of HIV permissiveness Sylvie Rato, Antonio Rausell, Miguel Munoz, Amalio Telenti, Angela Ciuffi O8 A capsid-dependent integration program linking T cell activation to HIV-1 gene expression Alexander Zhyvoloup, Anat Melamed, Ian Anderson, Delphine Planas, Janos Kriston-Vizi, Robin Ketteler, Chen-Hsuin Lee, Andy Merritt, Petronela Ancuta, Charles Bangham, Ariberto Fassati O9 Characterisation of new RNA polymerase III and RNA polymerase II transcriptional promoters in the Bovine Leukemia Virus genome Anthony Rodari, Benoit Van Driessche, Mathilde Galais, Nadége Delacourt, Sylvain Fauquenoy, Caroline Vanhulle, Anna Kula, Arsène Burny, Olivier Rohr, Carine Van Lint O10 Tissue-specific dendritic cells differentially modulate latent HIV-1 reservoirs Thijs van Montfort, Renee van der Sluis, Dave Speijer, Ben Berkhout Session 4: RNA trafficking & packaging O11 A novel cis-acting element affecting HIV replication Bo Meng, Andrzej Rutkowski, Neil Berry, Lars Dölken, Andrew Lever O12 Tolerance of HIV’s late gene expression towards stepwise codon adaptation Thomas Schuster, Benedikt Asbach, Ralf Wagner Session 5: Assembly & release O13 Importance of the tax-inducible actin-bundling protein fascin for transmission of human T cell leukemia virus Type 1 (HTLV-1) Christine Gross, Veit Wiesmann, Martina Kalmer, Thomas Wittenberg, Jan Gettemans, Andrea K. Thoma-Kress O14 Lentiviral nef proteins antagonize TIM-mediated inhibition of viral release Minghua Li, Eric O. Freed, Shan-Lu Liu Session 6: Pathogenesis & evolution O15 SEVI and semen prolong the half-life of HIV-1 Janis Müller, Jan Münch O16 CD169+ macrophages mediate retrovirus trans-infection of permissive lymphocytes to establish infection in vivo Xaver Sewald, Pradeep Uchil, Mark Ladinsky, Jagadish Beloor, Ruoxi Pi, Christin Herrmann, Nasim Motamedi, Thomas Murooka, Michael Brehm, Dale Greiner, Thorsten Mempel, Pamela Bjorkman, Priti Kumar, Walther Mothes O17 Efficient replication of a vpu containing SIVagm construct in African Green Monkeys requires an HIV-1 nef gene Simone Joas, Erica Parrish, Clement Wesley Gnanadurai, Edina Lump, Christina M. Stürzel, Nicholas F. Parrish, Ulrike Sauermann, Katharina Töpfer, Tina Schultheiss, Steven Bosinger, Guido Silvestri, Cristian Apetrei, Nicholas Huot, Michaela Müller-Trutwin, Daniel Sauter, Beatrice H. Hahn, Christiane Stahl-Hennig, Frank Kirchhoff O18 Reprogramming initiates mobilization of endogenous mutagenic LINE-1, Alu and SVA retrotransposons in human induced pluripotent stem cells with consequences for host gene expression Gerald Schumann, Sabine Jung-Klawitter, Nina V. Fuchs, Kyle R. Upton, Martin Muñoz-Lopez, Ruchi Shukla, Jichang Wang, Marta Garcia-Canadas, Cesar Lopez-Ruiz, Daniel J. Gerhardt, Attila Sebe, Ivana Grabundzija, Patricia Gerdes, Sylvia Merkert, Andres Pulgarin, Anja Bock, Ulrike Held, Anett Witthuhn, Alexandra Haase, Ernst J. Wolvetang, Ulrich Martin, Zoltán Ivics, Zsuzsanna Izsvák, J. Garcia-Perez, Geoffrey J. Faulkner O19 NF-κB activation induces expression of human endogenous retrovirus and particle production Tara Hurst, Aris Katzourakis, Gkikas Magiorkinis Session 7a and b: Innate sensing & intrinsic immunity O20 Identification of the phosphatase acting on T592 in SAMHD1 during M/G1 transition Kerstin Schott, Rita Derua, Janna Seifried, Andreas Reuter, Heike Schmitz, Christiane Tondera, Alberto Brandariz-Nuñez, Felipe Diaz-Griffero, Veerle Janssens, Renate König O21 Vpx overcomes a SAMHD1-independent block to HIV reverse transcription that is specific to resting CD4 T cells Hanna-Mari Baldauf, Lena Stegmann, Sarah-Marie Schwarz, Maud Trotard, Margarethe Martin, Gina Lenzi, Manja Burggraf, Xiaoyu Pan, Oliver I. Fregoso, Efrem S. Lim, Libin Abraham, Elina Erikson, Laura Nguyen, Ina Ambiel, Frank Rutsch, Renate König, Baek Kim, Michael Emerman, Oliver T. Fackler, Oliver T. Keppler O22 The role of SAMHD1 in antiviral restriction and immune sensing in the mouse Sabine Wittmann, Rayk Behrendt, Bianca Volkmann, Kristin Eissmann, Thomas Gramberg O23 T cells expressing reduced restriction factors are preferentially infected in therapy naïve HIV-1 patients Sebastian Bolduan, Herwig Koppensteiner, Stefanie Regensburg, Ruth Brack-Werner, Rika Draenert, Michael Schindler O24 cGAS-mediated innate immunity spreads through HIV-1 env-induced membrane fusion sites from infected to uninfected primary HIV-1 target cells Aurélie Ducroux, Shuting Xu, Aparna Ponnurangam, Sergej Franz, Angelina Malassa, Ellen Ewald, Christine Goffinet O25 Perturbation of innate RNA and DNA sensing by human T cell leukemia virus type 1 oncoproteins Sin-Yee Fung, Ching-Ping Chan, Chun-Kit Yuen, Kin-Hang Kok, Chin-Ping Chan, Dong-Yan Jin O26 Induction and anti-viral activity of Interferon α subtypes in HIV-1 infection Ulf Dittmer O27 Vpu-mediated counteraction of tetherin is a major determinant of HIV-1 interferon resistance Dorota Kmiec, Shilpa Iyer, Christina Stürzel, Daniel Sauter, Beatrice Hahn, Frank Kirchhoff O28 DNA repair protein Rad18 restricts HIV-1 and LINE-1 life cycle Yasuo Ariumi, Mariko Yasuda-Inoue, Koudai Kawano, Satoshi Tateishi, Priscilla Turelli O29 Natural mutations in IFITM3 allow escape from post-translational regulation and toggle antiviral specificity Alex Compton, Nicolas Roy, Françoise Porrot, Anne Billet, Nicoletta Casartelli, Jacob Yount, Chen Liang, Oliver Schwartz Session 8: Adaptive immunity & immune evasion O30 Observing evolution in HIV-1 infection: phylogenetics and mutant selection windows to infer the influence of the autologous antibody response on the viral quasispecies Carsten Magnus, Lucia Reh, Penny Moore, Therese Uhr, Jacqueline Weber, Lynn Morris, Alexandra Trkola O31 Dose and subtype specific analyses of the anti-HIV effects of IFN-alpha family members Rashel V. Grindberg, Erika Schlaepfer, Gideon Schreiber, Viviana Simon, Roberto F. Speck Session 9: Novel antiviral strategies O32 LEDGIN-mediated inhibition of the integrase-LEDGF/p75 interaction reduces reactivation of residual latent HIV Zeger Debyser, Lenard Vranckx, Jonas Demeulemeester, Suha Saleh, Eric Verdin, Anna Cereseto, Frauke Christ, Rik Gijsbers O33 NKG2D-mediated clearance of reactivated viral reservoirs by natural killer cells O34 Inhibition of HIV reactivation in brain cells by AAV-mediated delivery of CRISPR/Cas9 O35 CRISPR-Cas9 as antiviral: potent HIV-1 inhibition, but rapid virus escape and the subsequent design of escape-proof antiviral strategies Ben Berkhout, Gang Wang, Na Zhao, Atze T. Das Session 10: Recent advances in HIV vaccine development O36 Priming with a potent HIV-1 DNA vaccine frames the quality of T cell and antibody responses prior to a poxvirus and protein boost Benedikt Asbach, Josef Köstler, Beatriz Perdiguero, Mariano Esteban, Bertram L. Jacobs, David C. Montefiori, Celia C. LaBranche, Nicole L. Yates, Georgia D. Tomaras, Guido Ferrari, Kathryn E. Foulds, Mario Roederer, Gary Landucci, Donald N. Forthal, Michael S. Seaman, Natalie Hawkins, Steven G. Self, Sanjay Phogat, James Tartaglia, Susan W. Barnett, Brian Burke, Anthony D. Cristillo, Song Ding, Jonathan L. Heeney, Giuseppe Pantaleo, Ralf Wagner O37 Passive immunisation with a neutralising antibody against HIV-1 Env prevents infection of the first cells in a mucosal challenge rhesus monkey model Christiane Stahl-Hennig, Viktoria Stab, Armin Ensser, Ulrike Sauermann, Bettina Tippler, Dennis Burton, Matthias Tenbusch, Klaus Überla O38 HIV antibody Fc-glycoforms drive B cell affinity maturation Galit Alter, Giuseppe Lofano, Anne-Sophie Dugast, Viraj Kulkarni, Todd Suscovich Poster presentations Topic 1: Entry & uncoating P1 Dynein light chain is required for murine leukemia virus infection Tatiana Opazo, Felipe Barraza, Diego Herrera, Andrea Garces, Tomas Schwenke, Diego Tapia, Jorge Cancino, Gloria Arriagada P2 Peptide paratope mimics of the broadly neutralising HIV-1 antibody b12 Christina Haußner, Dominik Damm, Anette Rohrhofer, Barbara Schmidt, Jutta Eichler P3 Investigating cellular pathways involved in the transmission of HIV-1 between dendritic cells and T cells using RNAi screening techniques Rebecca Midgley, James Wheeldon, Vincent Piguet P4 Co-receptor tropism in HIV-1, HIV-2 monotypic and dual infections Priyanka Khopkar, Megha Rohamare, Smita Kulkarni P5 Characterisation of the role of CIB1 and CIB2 as HIV-1 helper factors Ana Godinho-Santos, Allan Hance, Joao Goncalves, Fabrizio Mammano P6 Buffering deleterious polymorphisms in the highly constrained C2 region of HIV-1 envelope by the flexible V3 domain Romain Gasser, Meriem Hamoudi, Martina Pellicciotta, Zhicheng Zhou, Clara Visdeloup, Philippe Colin, Martine Braibant, Bernard Lagane, Matteo Negroni P7 Entry inhibition of HERV-K(HML-2) by an Env-IgG fusion protein Jula Wamara, Norbert Bannert Topic 2: Reverse transcription & integration P8 The R263K/H51Y resistance substitutions in HIV integrase decreases levels of integrated HIV DNA over time Thibault Mesplede, Nathan Osman, Kaitlin Anstett, Jiaming Calvin Liang, Hanh Thi Pham, Mark Wainberg P9 The Retrovirus Integration Database (RID) Wei Shao, Jigui Shan, Mary Kearney, Xiaolin Wu, Frank Maldarelli, John Mellors, Brian Luke, John Coffin, Stephen Hughes P10 The small molecule 3G11 inhibits HIV-1 reverse transcription Thomas Fricke, Silvana Opp, Caitlin Shepard, Dmitri Ivanov, Baek Kim, Jose Valle-Casuso, Felipe Diaz-Griffero P11 Dual and opposite regulation of HIV-1 integration by hRAD51: impact on therapeutical approaches using homologous DNA repair modulators Vincent Parissi P12 A flexible motif essential for integration by HIV-1 integrase Marine Kanja, Pierre Cappy, Matteo Negroni, Daniela Lener P13 Interaction between HIV-1 integrase and the host protein Ku70: identification of the binding site and study of the influence on integrase-proteasome interplay Ekaterina Knyazhanskaya, Andrey Anisenko, Timofey Zatsepin, Marina Gottikh P14 Normalisation based method for deep sequencing of somatic retroelement integrations in human genome Alexander Komkov, Anastasia Minervina, Gaiaz Nugmanov, Vadim Nazarov, Konstantin Khodosevich, Ilgar Mamedov, Yuri Lebedev Topic 3: Transcription and latency P15 BCA2/RABRING7 restricts HIV-1 transcription by preventing the nuclear translocation of NF-κB Marta Colomer-Lluch, Ruth Serra-Moreno P16 MATR3 post-transcriptional regulation of HIV-1 transcription during latency Ambra Sarracino, Anna Kula, Lavina Gharu, Alexander Pasternak, Carine Van Lint, Alessandro Marcello P17 HIV-1 tat intersects the SUMO pathway to regulate HIV-1 promoter activity Ann Marie McCartin, Anurag Kulkarni, Valentin Le Douce, Virginie Gautier P18 Conservation in HIV-1 Vpr guides tertiary gRNA folding and alternative splicing Ann Baeyens, Evelien Naessens, Anouk Van Nuffel, Karin Weening, Anne-Marie Reilly, Eva Claeys, Wim Trypsteen, Linos Vandekerckhove, Sven Eyckerman, Kris Gevaert, Bruno Verhasselt P19 The majority of reactivatable latent HIV are genetically distinct Hoi Ping Mok, Nicholas Norton, Axel Fun, Jack Hirst, Mark Wills, Andrew Lever P20 Do mutations in the tat exonic splice enhancer contribute to HIV-1 latency? Nicholas Norton, Hoi Ping Mok, Jack Hirst, Andrew Lever P21 Culture-to-Ct: A fast and direct RT-qPCR HIV gene reactivation screening method using primary T cell culture Valentin Le Douce, Ann Marie McCartin, Virginie Gautier P22 A novel approach to define populations of early silenced proviruses Dalibor Miklik, Filip Senigl, Jiri Hejnar Topic 4: RNA trafficking & packaging P23 Functional analysis of the structure and conformation of HIV-1 genome RNA DIS Jun-ichi Sakuragi, Sayuri Sakuragi, Masaru Yokoyama, Tatsuo Shioda, Hironori Sato P24 Regulation of foamy viral env splicing controls gag and pol expression Jochen Bodem, Rebecca Moschall, Sarah Denk, Steffen Erkelenz, Christian Schenk, Heiner Schaal Topic 5: Assembly & release P25 Transfer of HTLV-1 p8 to target T cells depends on VASP: a novel interaction partner of p8 Norbert Donhauser, Ellen Socher, Sebastian Millen, Heinrich Sticht, Andrea K. Thoma-Kress P26 COL4A1 and COL4A2 are novel HTLV-1 tax targets with a putative role in virus transmission Christine Gross, Sebastian Millen, Melanie Mann, Klaus Überla, Andrea K. Thoma-Kress P27 The C terminus of foamy virus gag protein is required for particle formation, and virus budding: starting assembly at the C terminus? Guochao Wei, Matthew J. Betts, Yang Liu, Timo Kehl, Robert B. Russell, Martin Löchelt P28 Generation of an antigen-capture ELISA and analysis of Rec and Staufen-1 effects on HERV-K(HML-2) virus particle production Oliver Hohn, Saeed Mostafa, Kirsten Hanke, Stephen Norley, Norbert Bannert P29 Antagonism of BST-2/tetherin is a conserved function of primary HIV-2 Env glycoproteins Chia-Yen Chen, Masashi Shingai, Pedro Borrego, Nuno Taveira, Klaus Strebel P30 Mutations in the packaging signal region of the HIV-1 genome cause a late domain mutant phenotype Chris Hellmund, Bo Meng, Andrew Lever P31 p6 regulates membrane association of HIV-1 gag Melanie Friedrich, Friedrich Hahn, Christian Setz, Pia Rauch, Kirsten Fraedrich, Alina Matthaei, Petra Henklein, Maximilian Traxdorf, Torgils Fossen, Ulrich Schubert Topic 6: Pathogenesis & evolution P32 Molecular and structural basis of protein evolution during viral adaptation Aya Khwaja, Meytal Galilee, Akram Alian P33 HIV-1 enhancement and neutralisation by soluble gp120 and its role for the selection of the R5-tropic “best fit” Birco Schwalbe, Heiko Hauser, Michael Schreiber P34 An insertion of seven amino acids in the Env cytoplasmic tail of Human Immunodeficiency Virus type 2 (HIV-2) selected during disease progression enhances viral replication François Dufrasne, Mara Lucchetti, Patrick Goubau, Jean Ruelle P35 Cell-associated HIV-1 unspliced to multiply spliced RNA ratio at 12 weeks ART correlates with markers of immune activation and apoptosis and predicts the CD4 T-cell count at 96 weeks ART Mirte Scherpenisse, Ben Berkhout, Alexander Pasternak P36 Faster progression in non-B subtype HIV-1-infected patients than Korean subclade of subtype B is accompanied by higher variation and no induction of gross deletion in non-B nef gene by Korean red ginseng treatment Young-Keol Cho, Jungeun Kim, Daeun Jeong P37 Aberrant expression of ERVWE1 endogenous retrovirus and overexpression of TET dioxygenases are characteristic features of seminoma Katerina Trejbalova, Martina Benesova, Dana Kucerova, Zdenka Vernerova, Rachel Amouroux, Petra Hajkova, Jiri Hejnar P38 Life history of the oldest lentivirus: characterisation of ELVgv integrations and the TRIM5 selection pattern in dermoptera Daniel Elleder, Tomas Hron, Helena Farkasova, Abinash Padhi, Jan Paces P39 Characterisation of a highly divergent endogenous retrovirus in the equine germ line Henan Zhu, Robert Gifford, Pablo Murcia P40 The emergence of pandemic retroviral infection in small ruminants Maria Luisa Carrozza, Anna-Maria Niewiadomska, Maurizio Mazzei, Mounir Abi-Said, Joseph Hughes, Stéphane Hué, Robert Gifford P41 Near full-length genome (NFLG) Characterisation of HIV-1 subtype B identified in South Africa Adetayo Obasa, Graeme Jacobs, Susan Engelbrecht P42 Acquisition of Vpu-mediated tetherin antagonism by an HIV-1 group O strain Katharina Mack, Kathrin Starz, Daniel Sauter, Matthias Geyer, Frederic Bibollet-Ruche, Christina Stürzel, Marie Leoz, Jean Christophe Plantier, Beatrice H. Hahn, Frank Kirchhoff P43 The human endogenous retrovirus type K is involved in cancer stem cell markers expression and in human melanoma malignancy Ayele Argaw-Denboba, Emanuela Balestrieri, Annalucia Serafino, Ilaria Bucci, Chiara Cipriani, Corrado Spadafora, Paolo Sinibaldi-Vallebona, Claudia Matteucci P44 Natural infection of Indian non-human primates by unique lentiviruses S. Nandi Jayashree, Ujjwal Neogi, Anil K. Chhangani, Shravan Sing Rathore, Bajrang R. J. Mathur P45 Free cervical cancer screening among HIV-positive women receiving antiretroviral treatment in Nigeria Adeyemi Abati P46 Molecular evolutionary status of feline immunodeficiency virus in Turkey B. Taylan Koç, Tuba Çiğdem Oğuzoğlu Topic 7: Innate sensing & intrinsic immunity P47 Cell-to-cell contact with HTLV-1-infected T cells reduces dendritic cell immune functions and contributes to infection in trans. Takatoshi Shimauchi, Stephan Caucheteux, Jocelyn Turpin, Katja Finsterbusch, Charles Bangham, Yoshiki Tokura, Vincent Piguet P48 Deciphering the mechanisms of HIV-1 exacerbation induced by Mycobacterium tuberculosis in monocytes/macrophages Shanti Souriant, Luciana Balboa, Karine Pingris, Denise Kviatcowsky, Brigitte Raynaud-Messina, Céline Cougoule, Ingrid Mercier, Marcelo Kuroda, Pablo González-Montaner, Sandra Inwentarz, Eduardo Jose Moraña, Maria del Carmen Sasiain, Olivier Neyrolles, Isabelle Maridonneau-Parini, Geanncarlo Lugo-Villarino, Christel Vérollet P49 The SAMHD1-mediated inhibition of LINE-1 retroelements is regulated by phosphorylation Alexandra Herrmann, Sabine Wittmann, Caitlin Shepard, Dominique Thomas, Nerea Ferreirós Bouzas, Baek Kim, Thomas Gramberg P50 Activities of nuclear envelope protein SUN2 in HIV infection Xavier Lahaye, Anvita Bhargava, Takeshi Satoh, Matteo Gentili, Silvia Cerboni, Aymeric Silvin, Cécile Conrad, Hakim Ahmed-Belkacem, Elisa C. Rodriguez, Jean-François Guichou, Nathalie Bosquet, Matthieu Piel, Roger Le Grand, Megan King, Jean-Michel Pawlotsky, Nicolas Manel P51 Activation of TLR7/8 with a small molecule agonist induces a novel restriction to HIV-1 infection of monocytes Henning Hofmann, Benedicte Vanwalscappel, Nicolin Bloch, Nathaniel Landau P52 Steady state between the DNA polymerase and Rnase H domain activities of reverse transcriptases determines the sensitivity of retroviruses to inhibition by APOBEC3 proteins Stanislav Indik, Benedikt Hagen P53 HIV restriction in mature dendritic cells is related to p21 induction and p21-mediated control of the dNTP pool and SAMHD1 activity. José Carlos Valle-Casuso, Awatef Allouch, Annie David, Françoise Barré-Sinoussi, Michaela Müller-Trutwin, Monsef Benkirane, Gianfranco Pancino, Asier Saez-Cirion P54 IFITM protens restrict HIV-1 protein synthesis Wing-Yiu Lee, Chen Liang, Richard Sloan P55 Characterisation and functional analysis of the novel restriction factor Serinc5 Bianca Schulte, Silvana Opp, Felipe Diaz-Griffero P56 piRNA sequences are common in Human Endogenous Retroviral Sequences (HERVs): An antiretroviral restriction mechanism? Jonas Blomberg, Luana Vargiu, Patricia Rodriguez-Tomé, Enzo Tramontano, Göran Sperber P57 Ferroportin restricts HIV-1 infection in sickle cell disease Namita Kumari, Tatiana Ammosova, Sharmeen Diaz, Patricia Oneal, Sergei Nekhai P58 APOBEC3G modulates the response to antiretroviral drugs in humanized mice Audrey Fahrny, Gustavo Gers-Huber, Annette Audigé, Roberto F. Speck, Anitha Jayaprakash, Ravi Sachidanandam, Matt Hernandez, Marsha Dillon-White, Viviana Simon P59 High-throughput epigenetic analysis of evolutionarily young endogenous retrovirus presents in the mule deer (Odocoileus hemionus) genome Tomas Hron, Helena Farkasova, Daniel Elleder P60 Characterisation of the expression of novel endogenous retroviruses and immune interactions in a macaque model Neil Berry, Emmanuel Maze, Claire Ham, Neil Almond, Greg Towers, Robert Belshaw P61 HIV-1 restriction by orthologs of SERINC3 and SERINC5 Patrícia de Sousa-Pereira, Joana Abrantes, Massimo Pizzato, Pedro J. Esteves, Oliver T. Fackler, Oliver T. Keppler, Hanna-Mari Baldauf P62 TRIM19/PML restricts HIV infection in a cell type-dependent manner Bianca Volkmann, Tanja Kahle, Kristin Eissmann, Alexandra Herrmann, Sven Schmitt, Sabine Wittmann, Laura Merkel, Nina Reuter, Thomas Stamminger, Thomas Gramberg P63 Recent invasion of the mule deer genome by a retrovirus Helena Farkasova, Tomas Hron, Daniel Elleder P64 Does the antiviral protein SAMHD1 influence mitochondrial function? Ilaria Dalla Rosa, Kate Bishop, Antonella Spinazzola, Harriet Groom P65 cGAMP transfers intercellularly via HIV-1 Env-mediated cell–cell fusion sites and triggers an innate immune response in primary target cells Shuting Xu, Aurélie Ducroux, Aparna Ponnurangam, Sergej Franz, Gabrielle Vieyres, Mathias Müsken, Thomas Zillinger, Angelina Malassa, Ellen Ewald, Veit Hornung, Winfried Barchet, Susanne Häussler, Thomas Pietschmann, Christine Goffinet P66 Pre-infection transcript levels of FAM26F in PBMCS inform about overall plasma viral load in acute and postacute phase after SIV-infection Ulrike Sauermann, Aneela Javed, Nicole Leuchte, Gabriela Salinas, Lennart Opitz, Christiane Stahl-Hennig, Sieghart Sopper P67 Sequence-function analysis of three T cell receptors targeting the HIV-1 p17 epitope SLYNTVATL Christiane Mummert, Christian Hofmann, Angela G. Hückelhoven, Silke Bergmann, Sandra M. Müller-Schmucker, Ellen G. Harrer, Jan Dörrie, Niels Schaft, Thomas Harrer P68 An immunodominant region of the envelope glycoprotein of small ruminant lentiviruses may function as decoy antigen Laure Cardinaux, M.-L. Zahno, H.-R. Vogt, R. Zanoni, G. Bertoni P69 Impact of immune activation, immune exhaustion, broadly neutralising antibodies and viral reservoirs on disease progression in HIV-infected children Maximilian Muenchhoff, Philip Goulder, Oliver Keppler Topic 9: Novel antiviral strategies P70 Identification of natural compounds as new antiviral products by bioassay-guided fractionation Alexandra Herrmann, Stephanie Rebensburg, Markus Helfer, Michael Schindler, Ruth Brack-Werner P71 The PPARG antagonism disconnects the HIV replication and effector functions in Th17 cells Yuwei Zhang, Huicheng Chen, Delphine Planas, Annie Bernier, Annie Gosselin, Jean-Pierre Routy, Petronela Ancuta P72 Characterisation of a multiresistant subtype AG reverse transcriptase: AZT resistance, sensitivity to RNase H inhibitors and inhibitor binding Birgitta Wöhrl, Anna Schneider, Angela Corona, Imke Spöring, Mareike Jordan, Bernd Buchholz, Elias Maccioni, Roberto Di Santo, Jochen Bodem, Enzo Tramontano, Kristian Schweimer P73 Insigths into the acetylation pattern of HDAC inhibitors and their potential role in HIV therapy Christian Schölz, Brian Weinert, Sebastian Wagner, Petra Beli, Yasuyuki Miyake, Jun Qi, Lars Jensen, Werner Streicher, Anna McCarthy, Nicholas Westwood, Sonia Lain, Jürgen Cox, Patrick Matthias, Matthias Mann, James Bradner, Chunaram Choudhary P74 HPV-derived and seminal amyloid peptides enhance HIV-1 infection and impair the efficacy of broadly neutralising antibodies and antiretroviral drugs Marcel Stern, Oliver T. Keppler P75 D(−)lentiginosine inhibits both proliferation and virus expression in cells infected by HTLV-1 in vitro Elena Valletta, Caterina Frezza, Claudia Matteucci, Francesca Marino-Merlo, Sandro Grelli, Anna Lucia Serafino, Antonio Mastino, Beatrice Macchi P76 HIV-1 resistance analyses of the Cape Winelands districts, South Africa Sello Mikasi, Graeme Jacobs, Susan Engelbrecht Topic 10: Recent advances in HIV vaccine development P77 Induction of complex retrovirus antigen-specific immune responses by adenovirus-based vectors depends on the order of vector administration Meike Kaulfuß, Sonja Windmann, Wibke Bayer P78 Direct impact of structural properties of HIV-1 Env on the regulation of the humoral immune response Rebecca Heß, Michael Storcksdieck gen. Bonsmann, Viktoria Stab, Carsten Kirschning, Bernd Lepenies, Matthias Tenbusch, Klaus Überla P79 Lentiviral virus-like particles mediate gerenration of T-follicular helper cells in vitro Anne Kolenbrander, Klaus Überla, Vladimir Temchura P80 Recruitment of HIV-1 Vpr to DNA damage sites and protection of proviral DNA from nuclease activity Kenta Iijima, Junya Kobayashi, Yukihito Ishizaka
- Full Text
- View/download PDF
222. Leadership for the church: The shepherd model
- Author
-
K. Thomas Resane
- Subjects
Ecclesiastical leadership ,shepherd ,shepherd-leader ,sheep ,pastoral care’ courage ,guidance ,The Bible ,BS1-2970 ,Practical Theology ,BV1-5099 - Abstract
The scope of this article is to expand the shepherd model of leadership functions as portrayed by the shepherd metaphor. The identification and the biblical usage of the shepherd and the sheep is explored, with special focus on the role of the shepherd. This role is identified as that of caring, courage, and guidance. The caring function includes activities such as restoration, feeding, watering, grooming, shearing, delivering lambs, leading, and protection. The function of courage focuses on activities of assuming responsibility, serving and participating in change. The function of guidance gives a special highlight on hodegos [leader or guide] – to lead or to guide in regard to a decision or future course of action. This is where the leadership training is based. The conclusion is the call for leaders in the ecclesiastical community to pursue the shepherd-leader model for the advance and the effectiveness of the mission Dei [mission of God] in the world.
- Published
- 2014
223. The enforcement of the BCEA and waiters: Will they gain or lose?
- Author
-
L. J. Bothma and K. Thomas
- Subjects
Management. Industrial management ,HD28-70 ,Business ,HF5001-6182 ,Economics as a science ,HB71-74 - Abstract
This study, conducted in Bloemfontein, found wide discrepancies between the prescriptions of the Basic Conditions of Employment Act and the actual working conditions of waiters. In order to make waiters' situation compliant with the law, several changes will have to be made. However, it was also found that not all changes would necessarily benefit the waiters. Policy makers should therefore be cautious in addressing these discrepancies and making a sectoral determination for waiters.
- Published
- 2001
- Full Text
- View/download PDF
224. Pharmazeutische Technologie, herausgeg. von H. Sucker, P. Fuchs und P. Speiser, 319 Abb., 180 Tab., XX, 906 S., Preis DM 235,–, Georg Thieme Verlag, Stuttgart 1978
- Author
-
K. Thoma
- Subjects
Drug Discovery ,Pharmaceutical Science - Published
- 1980
- Full Text
- View/download PDF
225. Untersuchungen über die Funktion der Granula der basophilen Leukozyten
- Author
-
K. Thoma and A. Wiercinski
- Subjects
General Medicine - Published
- 1950
- Full Text
- View/download PDF
226. A Novel Tax-Responsive Reporter T-Cell Line to Analyze Infection of HTLV-1
- Author
-
Stefanie Heym, Pauline Krebs, Kristin Ott, Norbert Donhauser, Laura M. Kemeter, Florian Simon, Sebastian Millen, and Andrea K. Thoma-Kress
- Subjects
HTLV-1 ,Tax ,reporter T-cell line ,U3R ,Tax-responsive element ,HTLV-1 promoter ,Medicine - Abstract
Human T-cell leukemia virus type 1 (HTLV-1) infects CD4+ T-cells through close cell–cell contacts. The viral Tax-1 (Tax) protein regulates transcription by transactivating the HTLV-1 U3R promoter in the 5′ long terminal repeat of the integrated provirus. Here, we generated a clonal Tax-responsive T-cell line to track HTLV-1 infection at the single-cell level using flow cytometry, bypassing intracellular viral protein staining. Jurkat T-cells stably transduced with the SMPU vector carrying green fluorescent protein (GFP) under control of 18 × 21 bp Tax-responsive element repeats of the U3R were evaluated. Among 40 clones analyzed for Tax responsiveness, the top two were characterized. Upon overexpression of Tax, over 40% of the cells showed GFP positivity, and approximately 90% of the Tax-positive cells were GFP-positive, indicating efficient reporter activity. However, with CREB-deficient Tax mutant M47, both total GFP-positive cell counts and those within the Tax-positive group significantly decreased. Co-culture with chronically HTLV-1-infected MT-2 or C91-PL cells led to an average of 0.9% or 2.4% GFP-positive cells, respectively, confirming the suitability to monitor HTLV-1 transmission and that HTLV-1 infection is very low. Thus, the novel Tax-responsive reporter T-cell line is a suitable tool to monitor infection of HTLV-1 on the single-cell level.
- Published
- 2024
- Full Text
- View/download PDF
227. Propädeutische Arzneiformenlehre. Von E. Graf und H. Hamacher, Wissenschaftliche Verlagsgesellschaft, Stuttgart 1976, 66 Abb. und 17 Tab., 108 S., DM 29,50
- Author
-
K. Thoma
- Subjects
Pharmacology ,Pharmaceutical Science ,Pharmacology (medical) - Published
- 1978
- Full Text
- View/download PDF
228. Good Manufacturing Practices for Pharmaceuticals, A Plan for Total Qualitiy Control, von S.H. Willig, M.M. Tuckerman und W.S. Hitchings IV, 184 S., Preis $ 16.50, Marcel Dekker, Inc., New York 1975
- Author
-
K. Thoma
- Subjects
Engineering ,business.industry ,Drug Discovery ,Pharmaceutical Science ,business ,Management - Published
- 1976
- Full Text
- View/download PDF
229. Der Genotyp der Blutgruppen A1 und B, studiert an A1, B, A1O und BO-Bluten
- Author
-
K. Thoma
- Subjects
Traditional medicine ,Philosophy ,Pathology and Forensic Medicine - Published
- 1964
- Full Text
- View/download PDF
230. Tensile test on bricks
- Author
-
K. Thomas and D. C. O´Leary
- Subjects
Materials of engineering and construction. Mechanics of materials ,TA401-492 - Abstract
Not available
- Published
- 1971
- Full Text
- View/download PDF
231. Milk Transmission of Mammalian Retroviruses
- Author
-
Laura M. Kemeter, Alexandra Birzer, Stefanie Heym, and Andrea K. Thoma-Kress
- Subjects
retrovirus ,breast milk ,breastfeeding ,mammalian retrovirus ,oral route ,virus transmission ,Biology (General) ,QH301-705.5 - Abstract
The transmission of viruses from one host to another typically occurs through horizontal or vertical pathways. The horizontal pathways include transmission amongst individuals, usually through bodily fluids or excretions, while vertical transmission transpires from mother to their offspring, either during pregnancy, childbirth, or breastfeeding. While there are more than 200 human pathogenic viruses to date, only a small number of them are known to be transmitted via breast milk, including cytomegalovirus (CMV), human immunodeficiency virus type 1 (HIV-1), and human T cell lymphotropic virus type 1 (HTLV-1), the latter two belonging to the family Retroviridae. Breast milk transmission is a common characteristic among mammalian retroviruses, but there is a lack of reports summarizing our knowledge regarding this route of transmission of mammalian retroviruses. Here, we provide an overview of the transmission of mammalian exogenous retroviruses with a focus on Orthoretrovirinae, and we highlight whether they have been described or suspected to be transmitted through breast milk, covering various species. We also elaborate on the production and composition of breast milk and discuss potential entry sites of exogenous mammalian retroviruses during oral transmission.
- Published
- 2023
- Full Text
- View/download PDF
232. A novel positive feedback-loop between the HTLV-1 oncoprotein Tax and NF-κB activity in T-cells
- Author
-
Sebastian Millen, Lina Meretuk, Tim Göttlicher, Sarah Schmitt, Bernhard Fleckenstein, and Andrea K. Thoma-Kress
- Subjects
HTLV-1 ,Tax-1 ,NF-κB ,M22 ,Protein stability ,IKK2 ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Abstract Background Human T-cell leukemia virus type 1 (HTLV-1) infects primarily CD4+ T-lymphocytes and evoques severe diseases, predominantly Adult T-Cell Leukemia/ Lymphoma (ATL/L) and HTLV-1-associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP). The viral transactivator of the pX region (Tax) is important for initiating malignant transformation, and deregulation of the major signaling pathway nuclear factor of kappa B (NF-κB) by Tax represents a hallmark of HTLV-1 driven cancer. Results Here we found that Tax mutants which are defective in NF-κB signaling showed diminished protein expression levels compared to Tax wildtype in T-cells, whereas Tax transcript levels were comparable. Strikingly, constant activation of NF-κB signaling by the constitutive active mutant of inhibitor of kappa B kinase (IKK2, IKK-β), IKK2-EE, rescued protein expression of the NF-κB defective Tax mutants M22 and K1-10R and even increased protein levels of Tax wildtype in various T-cell lines while Tax transcript levels were only slightly affected. Using several Tax expression constructs, an increase of Tax protein occurred independent of Tax transcripts and independent of the promoter used. Further, Tax and M22 protein expression were strongly enhanced by 12-O-Tetradecanoylphorbol-13-Acetate [TPA; Phorbol 12-myristate 13-acetate (PMA)]/ ionomycin, inducers of NF-κB and cytokine signaling, but not by tumor necrosis factor alpha (TNF-α). On the other hand, co-expression of Tax with a dominant negative inhibitor of κB, IκBα-DN, or specific inhibition of IKK2 by the compound ACHP, led to a vast decrease in Tax protein levels to some extent independent of Tax transcripts in transiently transfected and Tax-transformed T-cells. Cycloheximide chase experiments revealed that co-expression of IKK2-EE prolongs the half-life of M22, and constant repression of NF-κB signaling by IκBα-DN strongly reduces protein stability of Tax wildtype suggesting that NF-κB activity is required for Tax protein stability. Finally, protein expression of Tax and M22 could be recovered by NH4Cl and PYR-41, inhibitors of the lysosome and the ubiquitin-activating enzyme E1, respectively. Conclusions Together, these findings suggest that Tax’s capability to induce NF-κB is critical for protein expression and stabilization of Tax itself. Overall, identification of this novel positive feedback loop between Tax and NF-κB in T-cells improves our understanding of Tax-driven transformation.
- Published
- 2020
- Full Text
- View/download PDF
233. The toxic marine dinoflagellate Alexandrium tamarense as the proximal cause of mortalities of farmed Atlantic salmon
- Author
-
A. D. Cembella, M. A. Quilliam, N. I. Lewis, A. G. Bauder, K. Thomas, J. Jellett, C. Carver, H. Ferguson, R. R. C.u.s.a.c.k., DELL'AVERSANO, CARMELA, Scientific Committee, A. D., Cembella, M. A., Quilliam, N. I., Lewi, A. G., Bauder, Dell'Aversano, Carmela, K., Thoma, J., Jellett, C., Carver, H., Ferguson, and R. R. C. u. s. a. c., K.
- Subjects
HILIC-MS ,PSP toxin - Published
- 2002
234. Recent Developments in Analytical Methods for Marine Toxins
- Author
-
M. Quilliam, K. Thomas, M. Laycock, J. Jellett, P. Hess, DELL'AVERSANO, CARMELA, Scientific Committee, M., Quilliam, Dell'Aversano, Carmela, K., Thoma, M., Laycock, J., Jellett, and P., Hess
- Subjects
PSP toxins - Published
- 2000
235. How Well are Serious Illness Conversations Documented and What are Patient and Physician Perceptions of These Conversations?
- Author
-
Daly J, Schmidt M, Thoma K, Xu Y, and Levy B
- Subjects
- Aged, Communication, Critical Illness, Female, Humans, Male, Retrospective Studies, Surveys and Questionnaires, Physician-Patient Relations, Physicians
- Abstract
Background: The Serious Illness Care Program (SICP), developed in 2011 by Ariadne Labs, restructures care so that knowing and then honoring patients' wishes becomes part of routine care. Objectives: 1) summarize patient perceptions of use of the Serious Illness Conversation Guide (SICG) components, 2) assess whether a serious illness conversation was documented in the electronic health record (EHR) and identify the SICG components that were included, 3) summarize clinician perceptions of use of the SICG components, and 4) assess the association of documented SICG components with the patient's perception of the SICG discussion. Methods: Clinicians at three family medicine offices were trained in serious illness conversations using the SICG. They documented their serious illness conversations in the medical record. Retrospective chart review for SICG components was conducted for patients. Patients and clinicians completed questionnaires about their experience with the SICG. Statistical analysis included the Pearson chi-square test for categorical variables and Cohen's kappa to determine agreement between clinician documentation and patient perception. Results: Eighty-nine patients consented and completed their baseline questionnaire. Mean age of the 89 patients was 72 years and 65 (73%) were female. Thirty (34%) medical records had one or more SICG components documented. Seventy-nine (89%) patients reported at least one individual component of the SICG being discussed. Clinicians reported they engaged in asking patients what is important to them at a mean of 5.9, with 7 being "all the time". There was slight agreement (kappa = .19) for patient perception and clinician documentation of discussing patient goals, but no agreement for any of the other SICG components. Conclusion: Even among trained clinicians, only one-third of patients had documentation of at least one SICG component. Only slight agreement was found between clinician documentation of SICG in the medical record and patient perception of SICG discussion.
- Published
- 2022
- Full Text
- View/download PDF
236. Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency.
- Author
-
Li J, Lei WT, Zhang P, Rapaport F, Seeleuthner Y, Lyu B, Asano T, Rosain J, Hammadi B, Zhang Y, Pelham SJ, Spaan AN, Migaud M, Hum D, Bigio B, Chrabieh M, Béziat V, Bustamante J, Zhang SY, Jouanguy E, Boisson-Dupuis S, El Baghdadi J, Aimanianda V, Thoma K, Fliegauf M, Grimbacher B, Korganow AS, Saunders C, Rao VK, Uzel G, Freeman AF, Holland SM, Su HC, Cunningham-Rundles C, Fieschi C, Abel L, Puel A, Cobat A, Casanova JL, Zhang Q, and Boisson B
- Subjects
- Animals, COS Cells, Cell Line, Chlorocebus aethiops, HEK293 Cells, Haploinsufficiency genetics, Humans, NF-kappa B genetics, Phenotype, Transcriptional Activation genetics, Common Variable Immunodeficiency genetics, NF-kappa B p50 Subunit genetics
- Abstract
Autosomal dominant (AD) NFKB1 deficiency is thought to be the most common genetic etiology of common variable immunodeficiency (CVID). However, the causal link between NFKB1 variants and CVID has not been demonstrated experimentally and genetically, and there has been insufficient biochemical characterization and enrichment analysis. We show that the cotransfection of NFKB1-deficient HEK293T cells (lacking both p105 and its cleaved form p50) with a κB reporter, NFKB1/p105, and a homodimerization-defective RELA/p65 mutant results in p50:p65 heterodimer-dependent and p65:p65 homodimer-independent transcriptional activation. We found that 59 of the 90 variants in patients with CVID or related conditions were loss of function or hypomorphic. By contrast, 258 of 260 variants in the general population or patients with unrelated conditions were neutral. None of the deleterious variants displayed negative dominance. The enrichment in deleterious NFKB1 variants of patients with CVID was selective and highly significant (P = 2.78 × 10-15). NFKB1 variants disrupting NFKB1/p50 transcriptional activity thus underlie AD CVID by haploinsufficiency, whereas neutral variants in this assay should not be considered causal., Competing Interests: Disclosures: S.J. Pelham became employed at Takeda UK Ltd. after contributing to this work. B. Grimbacher reported grants from BMBF, DFG, several pharmaceutical companies, and foundations, and personal fees from several pharmaceutical companies outside the submitted work. No other disclosures were reported., (© 2021 Li et al.)
- Published
- 2021
- Full Text
- View/download PDF
237. IL17 inhibition for psoriasis vulgaris and arthritis results in clinical and serological remission of coexistent pemphigus foliaceus.
- Author
-
Schauer F, Meiss F, Thoma K, and Kiritsi D
- Subjects
- Humans, Arthritis, Pemphigus diagnosis, Pemphigus drug therapy, Psoriasis complications, Psoriasis diagnosis, Psoriasis drug therapy
- Published
- 2021
- Full Text
- View/download PDF
238. A Curriculum for Teaching Clinical Efficiency Focusing on Specific Communication Skills While Maximizing the Electronic Health Record.
- Author
-
Skelly K, Shen W, Wilbur J, Thoma K, Endres J, Lynch A, Gaglioti A, and Rosenbaum M
- Subjects
- Communication, Curriculum, Documentation, Humans, Electronic Health Records, Physicians
- Abstract
Introduction: All physicians must learn comprehensive patient care delivery within the electronic health record (EHR). No studies have considered EHR communication training with an emphasis on clinical efficiency. This curriculum provides a method of teaching clinic efficiency while practicing effective patient communication in any EHR clinical situation. The target audience is resident physicians, fellow physicians, faculty physicians, and physician extenders practicing in a primary care setting where the EHR is present., Methods: This curriculum of four separate workshops provides a structured EHR approach while addressing communication strategies for preclinical preparation, rapport building, encounter initiation, agenda setting, and visit closure. The curriculum contains interactive presentations, tools, and an evaluation survey. Presenting efficiency issues with the EHR using the ATTEND mnemonic and agenda setting allows documentation while practicing communication techniques that maximize efficiency., Results: Postworkshop surveys revealed that participants felt the workshops were helpful (84%). One measurement of efficiency revealed improvement through decreased number of days to note completion after workshop participation. At the Program Directors Workshop, curriculum value was demonstrated by high attendance, with 94% feeling the workshops provided easily utilizable strategies., Discussion: The curriculum utilized only the EPIC EHR but would be generalizable. Future directions could include measurement of effective communication and visit efficiency through direct observation and expanded EHR timing data., (© 2020 Skelly et al.)
- Published
- 2020
- Full Text
- View/download PDF
239. Warning criteria for MEP monitoring during carotid endarterectomy: a retrospective study of 571 patients.
- Author
-
Malcharek MJ, Hesse J, Hesselbarth K, Thoma K, Wegner C, Sablotzki A, Hennig G, and Gille J
- Subjects
- Aged, Anesthetics pharmacology, Area Under Curve, Brain Ischemia diagnostic imaging, Evoked Potentials, Motor physiology, Evoked Potentials, Somatosensory physiology, False Positive Reactions, Female, Humans, Intraoperative Neurophysiological Monitoring methods, Male, Middle Aged, Neurophysiology, Neurosurgical Procedures methods, Retrospective Studies, Anesthesia, General methods, Endarterectomy, Carotid methods, Monitoring, Physiologic methods
- Abstract
Monitoring of transcranial electrical motor evoked potentials (tcMEP) during carotid endarterectomy (CEA) has been shown to effectively detect intraoperative cerebral ischemia. The unique purpose of this study was to evaluate changes of MEP amplitude (AMP), area under the curve (AUC) and signal morphology (MOR) as additional MEP warning criteria for clamping-associated ischemia during CEA. Therefore, the primary outcome was the number of MEP alerts (AMP, AUC and MOR) in the patients without postoperative motor deficit (false positives). We retrospectively reviewed data from 571 patients who received CEA under general anesthesia. Monitoring of somatosensory evoked potentials (SSEP) and tcMEP was performed in all cases (all-or-none MEP warning criteria). The percentages of false positives (primary parameter) of AMP, AUC and MOR were evaluated according to the postoperative motor outcome. In the cohort of 562 patients, we found significant SSEP/MEP changes in 56 patients (9.96%). In 44 cases (7.83%) a shunt was inserted. Nine patients (1.57%) were excluded due to MEP recording failure. False positives were registered for AMP, AUC and MOR changes in 121 (24.01%), 148 (29.36%) and 165 (32.74%) patients, respectively. In combination of AMP/AUC and AMP/AUC/MOR false positives were found in 9.52% and 9.33% of the patients. This study is the first to evaluate the correctness of the MEP warning criteria AMP, AUC and MOR with regard to false positive monitoring results in the context of CEA. All additional MEP warning criteria investigated produced an unacceptably high number of false positives and therefore may not be useful in carotid surgery for adequate detection of clamping-associated ischemia.
- Published
- 2020
- Full Text
- View/download PDF
240. Transition from Bullous Pemphigoid to Pemphigus Foliaceus: Intermolecular Epitope Spreading Thirteen Years after Initial Diagnosis.
- Author
-
Schauer F, Steinke H, Thoma K, and Kiritsi D
- Subjects
- Aged, Disease Progression, Enzyme-Linked Immunosorbent Assay, Epitopes, Female, Humans, Immunosuppressive Agents therapeutic use, Pemphigoid, Bullous drug therapy, Pemphigoid, Bullous immunology, Pemphigus drug therapy, Pemphigus immunology, Pemphigoid, Bullous complications, Pemphigus complications
- Published
- 2019
- Full Text
- View/download PDF
241. A new clinical variant of acquired reactive perforating dermatosis-like bullous pemphigoid.
- Author
-
Schauer F, Kern JS, Virtic O, Technau-Hafsi K, Meiss F, Thoma K, Athanasiou I, Sitaru C, Di Zenzo G, Izumi K, Nishie W, Shimizu H, Bruckner-Tuderman L, and Kiritsi D
- Subjects
- Aged, Autoantibodies blood, Autoantibodies immunology, Autoantigens immunology, Biopsy, Dystonin immunology, Female, Humans, Immunoglobulin E blood, Immunoglobulin E immunology, Male, Non-Fibrillar Collagens immunology, Pemphigoid, Bullous immunology, Pemphigoid, Bullous pathology, Collagen Type XVII, Pemphigoid, Bullous diagnosis, Skin pathology
- Published
- 2019
- Full Text
- View/download PDF
242. Acute DWI Reductions In Patients After Single Epileptic Seizures - More Common Than Assumed.
- Author
-
Hübers A, Thoma K, Schocke M, Fauser S, Ludolph AC, Kassubek J, and Pinkhardt EH
- Abstract
Background: Changes of cerebral diffusivity detected by magnetic resonance imaging (MRI) have been reported in epilepsy. Diffusion weighted imaging (DWI) detects changes in the distribution of water molecules by measuring the apparent diffusion coefficient (ADC) and is mainly used in the diagnosis of ischemic stroke. DWI changes in epilepsy were reported in status epilepticus (SE) or series of seizures. It remains unclear whether this phenomenon also occurs after single seizures. Accordingly, possible pathomechanisms have only been discussed on the presumed basis of ongoing epileptic brain activity. Methods: In this retrospective study, we systematically analyzed DWI alterations related to epileptic seizures in 454 patients who received MRI scanning within the first 24 h after seizure onset. Results: DWI restrictions not classified as ischemic stroke were observed in 18 patients (4%). We found DWI restrictions in 19% of patients with SE/seizure series and in 3% of patients after single focal and 2.5% after single generalized seizures. 17 patients with DWI alterations were diagnosed with a structural epilepsy. DWI signal decreased in the majority of patients within the first days and could not be detected in follow-up imaging >3 months. In all patients except one, DWI alterations were detected in the same hemisphere as the lesion. In the case of seizure series or SE, DWI restrictions mostly presented with a typical "garland-like" pattern alongside the cortical band or on the border of a defined lesion, while in isolated seizures, the restrictions were often rather subtle and small. Discussion: We show that DWI restrictions can be observed in patients after single epileptic seizures. As the vast majority of these patients was diagnosed with an epilepsy due to structural cerebral pathology, DWI restriction may reflect a higher vulnerability in these regions. This might also explain the fact that diffusivity changes were observed after single focal seizures as well as after multiple seizures or SE. The occurence itself on one side as well as the spatial pattern of this phenomenon on the other may thus not only be related to the duration of ictal activity, but to structural pathology.
- Published
- 2018
- Full Text
- View/download PDF
243. Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas.
- Author
-
Föll MC, Fahrner M, Gretzmeier C, Thoma K, Biniossek ML, Kiritsi D, Meiss F, Schilling O, Nyström A, and Kern JS
- Subjects
- Adult, Age of Onset, Aged, Aged, 80 and over, Bacteria metabolism, Carcinoma, Squamous Cell metabolism, Disease Progression, Epidermolysis Bullosa Dystrophica genetics, Female, Gene Expression Regulation, Neoplastic, Humans, Male, Middle Aged, Mutation, Neoplasm Metastasis, Skin Neoplasms metabolism, Tumor Microenvironment, Young Adult, Carcinoma, Squamous Cell microbiology, Carcinoma, Squamous Cell pathology, Epidermolysis Bullosa Dystrophica metabolism, Extracellular Matrix metabolism, Proteomics methods, Skin Neoplasms microbiology
- Abstract
In this study we used a genetic extracellular matrix (ECM) disease to identify mechanisms associated with aggressive behavior of cutaneous squamous cell carcinoma (cSCC). cSCC is one of the most common malignancies and usually has a good prognosis. However, some cSCCs recur or metastasize and cause significant morbidity and mortality. Known factors that are associated with aggressiveness of cSCCs include tumor grading, size, localization and microinvasive behavior. To investigate molecular mechanisms that influence biologic behavior we used global proteomic and histologic analyses of formalin-fixed paraffin-embedded tissue of primary human cSCCs. We compared three groups: non-recurring, non-metastasizing low-risk sporadic cSCCs; metastasizing sporadic cSCCs; and cSCCs from patients with recessive dystrophic epidermolysis bullosa (RDEB). RDEB is a genetic skin blistering and ECM disease caused by collagen VII deficiency. Patients commonly suffer from high-risk early onset cSCCs that frequently metastasize. The results indicate that different processes are associated with formation of RDEB cSCCs compared to sporadic cSCCs. Sporadic cSCCs show signs of UV damage, whereas RDEB cSCCs have higher mutational rates and display tissue damage, inflammation and subsequent remodeling of the dermal ECM as tumor initiating factors. Interestingly the two high-risk groups - high-risk metastasizing sporadic cSCCs and RDEB cSCCs - are both associated with tissue damage and ECM remodeling in gene-ontology enrichment and Search Tool for the Retrieval of Interacting Genes/Proteins analyses. In situ histologic analyses validate these results. The high-risk cSCCs also show signatures of enhanced bacterial challenge. Histologic analyses confirm correlation of bacterial colonization with worse prognosis. Collectively, this unbiased study - performed directly on human patient material - reveals that common microenvironmental alterations linked to ECM remodeling and increased bacterial challenges are denominators of high-risk cSCCs. The proteins identified here could serve as potential diagnostic markers and therapeutic targets in high-risk cSCCs., (Copyright © 2017 Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
244. Indoleamine 2,3-Dioxygenase Expression in Primary Cutaneous Melanoma Correlates with Breslow Thickness and Is of Significant Prognostic Value for Progression-Free Survival.
- Author
-
Rubel F, Kern JS, Technau-Hafsi K, Uhrich S, Thoma K, Häcker G, von Bubnoff N, Meiss F, and von Bubnoff D
- Subjects
- Adult, Aged, Aged, 80 and over, Antigen-Presenting Cells enzymology, Female, Humans, Indoleamine-Pyrrole 2,3,-Dioxygenase antagonists & inhibitors, Macrophages enzymology, Male, Melanoma immunology, Melanoma mortality, Melanoma pathology, Middle Aged, Prognosis, Skin Neoplasms immunology, Skin Neoplasms mortality, Skin Neoplasms pathology, Tumor Microenvironment, Indoleamine-Pyrrole 2,3,-Dioxygenase physiology, Melanoma enzymology, Skin Neoplasms enzymology
- Abstract
The enzyme indoleamine 2,3-dioxygenase (IDO) is emerging as a facilitator of cancer development through its effects on cancer-associated inflammation. Recent studies report a significant improvement of the response rates in melanoma patients to PD-1 antibodies when IDO inhibitors were added to the regimen. Data on IDO expression in primary human melanomas are, however, incomplete and conflicting. Here, we show that the level of IDO expression in primary human melanoma cells significantly correlates with Breslow thickness (P = 0.003), the presence of tumor-infiltrating lymphocytes (P = 0.029), and the intensity of the peritumoral inflammatory infiltrate (P = 0.001). The expression of IDO in melanoma cells predicted independently of Breslow thickness and tumor stage (P = 0.04). We further show that CD11c
+ dendritic cells and CD68+ macrophages in the microenvironment of melanomas express IDO. The level of IDO expression in antigen-presenting cells correlated positively to peritumoral inflammation (P = 0.001) but not to tumor-infiltrating lymphocytes. Significant negative correlation with progression-free survival was found for patients for whom antigen-presenting cells were very strongly IDO positive. These results suggest that IDO induction within melanoma cells may directly reflect tumor progression, whereas IDO in antigen-presenting cells may determine immune surveillance with impact on local and systemic tolerance., (Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
245. Acceptability and feasibility of a randomized clinical trial of oral naltrexone vs. placebo for women living with HIV infection: Study design challenges and pilot study results.
- Author
-
Cook RL, Weber KM, Mai D, Thoma K, Hu X, Brumback B, Karki M, Bryant K, Rathore M, Young M, and Cohen M
- Subjects
- Adult, Black or African American, Double-Blind Method, Female, Humans, Medication Adherence, Middle Aged, Pilot Projects, Substance-Related Disorders ethnology, Alcoholism ethnology, Alcoholism prevention & control, HIV Infections ethnology, Naltrexone administration & dosage, Narcotic Antagonists administration & dosage
- Abstract
Background: Women living with HIV/AIDS who drink alcohol are at increased risk for adverse health outcomes, but there is little evidence on best methods for reducing alcohol consumption in this population. We conducted a pilot study to determine the acceptability and feasibility of conducting a larger randomized clinical trial of naltrexone vs. placebo to reduce alcohol consumption in women living with HIV/AIDS., Methods: We designed the trial with input from community and scientific review. Women with HIV who reported current hazardous drinking (>7 drinks/week or ≥4 drinks per occasion) were randomly assigned to daily oral naltrexone (50mg) or placebo for 4months. We evaluated willingness to enroll, adherence to study medication, treatment side effects, and drinking and HIV-related outcomes., Results: From 2010 to 2012, 17 women enrolled (mean age 49years, 94% African American). Study participation was higher among women recruited from an existing HIV cohort study compared to women recruited from an outpatient HIV clinic. Participants took 73% of their study medication; 82% completed the final assessment (7-months). Among all participants, mean alcohol consumption declined substantially from baseline to month 4 (39.2 vs. 12.8 drinks/week, p<0.01) with continued reduction maintained at 7-months. Drinking reductions were similar in both naltrexone and placebo groups., Conclusions: A pharmacologic alcohol intervention was acceptable and feasible in women with HIV, with reduced alcohol consumption noted in women assigned to both treatment and placebo groups. However, several recruitment challenges were identified that should be addressed to enhance recruitment in future alcohol treatment trials., (Copyright © 2017 Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
246. Start-up of a full-scale deammonification SBR-treating effluent from digested sludge dewatering.
- Author
-
Lackner S, Thoma K, Gilbert EM, Gander W, Schreff D, and Horn H
- Subjects
- Ammonium Compounds, Anaerobiosis, Bacteria classification, Bacteria metabolism, Denitrification, Nitrification, Nitrites chemistry, Oxidation-Reduction, Time Factors, Bioreactors, Sewage chemistry
- Abstract
This study shows the start-up and operation of a full-scale sequencing batch reactor (SBR) with a volume of 550 m³ for deammonification of reject water from sludge dewatering over the first 650 days of operation. The SBR was operated with discontinuous aeration and achieved an optimum of around 85% of ammonium removal at a load of 0.17 kg m⁻³ d⁻¹. The application of batch tests for the activity measurement of aerobic ammonium and nitrite oxidizing bacteria and anaerobic ammonium oxidizing bacteria were proven to support the identification of setbacks in reactor operation. Furthermore, the calculation of the oxygen uptake rates from online oxygen measurements helped to explain the overall reactor performance. The aeration regime is a key parameter for stable operation of such an SBR for deammonification. At aeration/non-aeration time ranges from 6-9 min, the best results with respect to turnover rates and low nitrate production were achieved. Compared with the nitrification/denitrification SBR operated in parallel with methanol as the carbon source, a significant reduction in costs for energy and chemicals was achieved. The costs for maintenance slightly increased.
- Published
- 2015
- Full Text
- View/download PDF
247. Mortality trends and the epidemiological transition in Nauru.
- Author
-
Carter K, Soakai TS, Taylor R, Gadabu I, Rao C, Thoma K, and Lopez AD
- Subjects
- Adolescent, Adult, Cardiovascular Diseases mortality, Cause of Death trends, Confidence Intervals, Diabetes Mellitus mortality, Female, Humans, Life Tables, Male, Micronesia epidemiology, Middle Aged, Young Adult, Life Expectancy trends, Mortality trends
- Abstract
This article aims to examine the epidemiological transition in Nauru through analysis of available mortality data. Mortality data from death certificates and published material were used to construct life tables and calculate age-standardized mortality rates (from 1960) with 95% confidence intervals. Proportional mortality was calculated from 1947. Female life expectancy (LE) varied from 57 to 61 years with no significant trend. Age-standardized mortality for males (15-64 years) doubled from 1960-1970 to 1976-1981 and then decreased to 1986-1992, with LE fluctuating since then from 49 to 54 years. Proportional mortality from cardiovascular disease and diabetes increased substantially, reaching more than 30%. Nauru demonstrates a very long period of stagnation in life expectancy in both males and females as a consequence of the epidemiological transition, with major chronic disease mortality in adults showing no sustained downward trends over 40 years. Potential overinterpretation of trends from previous data due to lack of confidence intervals was highlighted.
- Published
- 2011
- Full Text
- View/download PDF
248. The human genome puzzle - the role of copy number variation in somatic mosaicism.
- Author
-
Mkrtchyan H, Gross M, Hinreiner S, Polytiko A, Manvelyan M, Mrasek K, Kosyakova N, Ewers E, Nelle H, Liehr T, Bhatt S, Thoma K, Gebhart E, Wilhelm S, Fahsold R, Volleth M, and Weise A
- Abstract
The discovery of copy number variations (CNV) in the human genome opened new perspectives in the study of the genetic causes of inherited disorders and the etiology of common diseases. Differently patterned instances of somatic mosaicism in CNV regions have been shown to be present in monozygotic twins and throughout different tissues within an individual. A single-cell-level investigation of CNV in different human cell types led us to uncover mitotically derived genomic mosaicism, which is stable in different cell types of one individual. A unique study of immortalized B-lymphoblastoid cell lines obtained with 20 year interval from the same two subjects shows that mitotic changes in CNV regions may happen early during embryonic development and seem to occur only once, as levels of mosaicism remained stable. This finding has the potential to change our concept of dynamic human genome variation. We propose that further genomic studies should focus on the single-cell level, to understand better the etiology and physiology of aging and diseases mediated by somatic variations.
- Published
- 2010
- Full Text
- View/download PDF
249. Bioabsorbable root analogue for closure of oroantral communications after tooth extraction: a prospective case-cohort study.
- Author
-
Thoma K, Pajarola GF, Grätz KW, and Schmidlin PR
- Subjects
- Adolescent, Adult, Biocompatible Materials, Calcium Phosphates, Cohort Studies, Female, Humans, Lactic Acid, Male, Middle Aged, Oroantral Fistula etiology, Polyesters, Polymers, Prospective Studies, Surgical Flaps, Tooth Root, Absorbable Implants, Oroantral Fistula surgery, Tooth Extraction adverse effects
- Abstract
Objective: To assess the clinical capacity of a bioabsorbable root analog to close oroantral perforations after extraction., Study Design: In this prospective case-cohort study, 20 consecutive patients with oroantral communications greater than 2 mm were treated with a bioabsorbable root analog (RootReplica). Patients were followed up clinically and radiographically for 3 months to monitor the healing process., Results: Root replicas could be placed in 14 patients, whereas 6 patients required the socket to be covered with a buccal sliding flap. In the latter cases, fragmentary roots or overly large defects prohibited replica fabrication or accurate fitting of the analog, respectively. Healing was uneventful in all patients, and epistaxis, swelling, or pain was observed only in patients treated with flaps., Conclusions: The method described is a valuable alternative method with which to close oroantral communications but cannot be performed in all patients because of technical limitations.
- Published
- 2006
- Full Text
- View/download PDF
250. Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype.
- Author
-
Renkl AC, Wussler J, Ahrens T, Thoma K, Kon S, Uede T, Martin SF, Simon JC, and Weiss JM
- Subjects
- Cell Differentiation drug effects, Cell Movement drug effects, Cells, Cultured, Cytokines metabolism, Dendritic Cells cytology, Dendritic Cells physiology, Humans, Langerhans Cells drug effects, Lymphocyte Culture Test, Mixed, Osteopontin, Phenotype, Recombinant Proteins, Dendritic Cells drug effects, Sialoglycoproteins pharmacology, Th1 Cells immunology
- Abstract
Osteopontin (OPN) has been shown to have T helper 1 (Th1) cytokine functions in cell-mediated immunity. Deficiency of OPN is linked to a reduced Th1 immune response in autoimmunity, infectious disease, and delayed-type allergy. Dendritic cells (DCs) are central for the induction of T-cell-mediated immunity, when initially flexible DCs are instructed by priming signals and tissue-derived factors to adopt Th1, Th2, or regulatory T-cell-inducing phenotypes. Although OPN influences the cytokine secretion of T cells and macrophages, its effects on DC polarization remain an important missing link in the understanding of OPN functions in Th1 immunity. Here we demonstrate that OPN promotes the emigration of human DCs from the epidermis and functionally activates myeloid-type DCs, augmenting their expression of HLA-DR, costimulatory, and adhesion molecules. OPN induces their Th1-promoting tumor necrosis factor alpha (TNF-alpha) and interleukin-12 (IL-12) secretion, and enhances their allostimulatory capacity. In mixed lymphocyte reactions (MLRs), OPN stimulates IL-12 secretion by DCs, inducing elevated interferon-gamma (IFN-gamma) production by T cells. Naive Th cells stimulated by OPN-activated DCs show a Th1-polarized cytokine production. Our findings identify OPN as an important tissue-derived factor that DCs encounter when traveling from peripheral sites of activation to secondary lymphatic organs, which induces DC maturation toward a Th1-promoting phenotype.
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.